Responses

Download PDFPDF

Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear
Free
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses [https://authors.bmj.com/after-submitting/rapid-responses/].
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses [https://www.bmj.com/company/journals-terms-and-conditions-for-rapid-responses/] and understand that your personal data will be processed in accordance with those terms and our privacy notice [https://www.bmj.com/company/your-privacy/].
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Going viral: mitigating risk in ophthalmology
    • Niku Dhillon, ST1 Ophthalmology NHS Grampian
    • Other Contributors:
      • Baljean Dhillon, Consultant Ophthalmology

    We read with interest the BMJ Editorial Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear1. This highlights the need for risk mitigation in the context of commonplace eye examinations using the slit-lamp biomicroscope and direct ophthalmoscope, both requiring very close proximity manoeuvres within a few centimetres of the patients’ eye, nose and mouth. Droplet spread during eye examination likely increases during these prolonged direct examination techniques. Those at most risk are trainees working in accident and emergency, opticians or acute care settings who are required to see patients presenting with “red eye” for which conjunctivitis is a common cause.

    Patients with conjunctivitis can be safely manged by the non-specialist using simple observation and history enquiry2 supplemented by a phone captured image. Remote-site consultation allows further discussion allowing an eye image and clinical details to be scrutinised without the requirement for on-site attendance. Currently, clinicians use mobile phone consultations to supplement and enhance care provision and it would seem prudent to adopt this more widely to minimise risk of Covid-19 transmission which might be acquired through public transport travel, waiting room exposure or face to face consultation. Notwithstanding confidentiality issues of commonly used freeware with private image messaging capabilities e.g Whatsap...

    Show More
    Conflict of Interest:
    None declared.